UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

EVALUATION OF HEMATOPOIETIC GROWTH-FACTORS - DEFINING RELEVANT CLINICAL END-POINTS IN GROWTH-FACTOR TRIALS

LINCH, DC; (1994) EVALUATION OF HEMATOPOIETIC GROWTH-FACTORS - DEFINING RELEVANT CLINICAL END-POINTS IN GROWTH-FACTOR TRIALS. EUROPEAN JOURNAL OF CANCER , 30A S40 - S43.

Full text not available from this repository.

Abstract

Initial evaluation of the therapeutic efficacy of haemopoietic growth factors involves assessment of their effects on the blood count, in various clinical situations. However, hard clinical data are also needed. Microbiologically documented infection is the ideal parameter but is difficult to measure. Consequently, the surrogate parameters of duration of fever and antibiotic usage are used instead. Febrile neutropenia is not a clinical endpoint, but merely a useful indicator to begin antibiotic therapy.To date, cost evaluations of growth factor use have relied on retrospective analyses of relevant clinical data including antibiotic usage, parenteral nutrition requirements, and duration of hospitalisation. Growth factors can reduce all these parameters in selected situations.Clinical data also suggest that growth factors facilitate chemotherapy dose optimisation and intensification, although the degree of intensification appears limited (20-40%). Currently, it is unclear whether such therapy confers benefit in terms of remission rates and survival.

Type: Article
Title: EVALUATION OF HEMATOPOIETIC GROWTH-FACTORS - DEFINING RELEVANT CLINICAL END-POINTS IN GROWTH-FACTOR TRIALS
Location: PARIS, FRANCE
Keywords: COLONY-STIMULATING FACTOR, BONE-MARROW TRANSPLANTATION, HIGH-DOSE CHEMOTHERAPY, CELL LUNG-CANCER, RECOMBINANT HUMAN INTERLEUKIN-3, PLACEBO-CONTROLLED TRIAL, NON-HODGKINS-LYMPHOMA, DOUBLE-BLIND, NEUTROPHIL MIGRATION, MALIGNANT-LYMPHOMA
URI: http://discovery.ucl.ac.uk/id/eprint/42268
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item